关于我们
公司简介
发展历程
董事会
联系我们
研发与技术
疾病领域
技术平台
研发中心
学术论著
产品介绍
产品管线
生产运营
临床资讯
临床研究项目
新闻中心
新冠相关
公司动态
投资者关系
公司公告
实时行情
联系方式
加入我们
人才理念
人才培养
人才招聘
博士后工作站
English
研发与技术
R&D and Technology
疾病领域
技术平台
研发中心
学术论著
Immunogenicity correlation in cynomolgus monkeys between Luminex‐d total IgG immunoassay and pseudovirion‐ d neutralization assay for a 14‐valent recombinant human papillomavirus vaccine
2022-08-30
999+
学术论著
上一篇:Rational Development of a Polysaccharide-Protein-Conjugated Nanoparticle Vaccine Against SARS-CoV-2 Variants and Streptococcus pneumoniae
下一篇:Lipid nanoparticle-encapsulated mRNA antibody provides long-term protection against SARS-CoV-2 in mice and hamsters
最新资讯
Efficacy Safety and Pharmacokinetics of Recombinant Human Coagulation Factor VIII (Omfiloctocog alfa) in Previously Treated Children with Severe Hemophilia A.
2022-08-30
Rational Development of a Polysaccharide-Protein-Conjugated Nanoparticle Vaccine Against SARS-CoV-2 Variants and Streptococcus pneumoniae
2022-08-30
Immunogenicity correlation in cynomolgus monkeys between Luminex‐d total IgG immunoassay and pseudovirion‐ d neutralization assay for a 14‐valent recombinant human papillomavirus vaccine
2022-08-30
Lipid nanoparticle-encapsulated mRNA antibody provides long-term protection against SARS-CoV-2 in mice and hamsters
2022-08-30